Immunology of endometriosis

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 18, Issue 2, 2004, Pages 245-263

  Dmowski, W Paul ^a,c   Braun, Donald P ^b  

^a RUSH MEDICAL COLLEGE   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

^c Institute for the Study and Treatment of Endometriosis   (United States)

Author keywords

Apoptosis; Chemokines; Cytokines; Endometriosis; Endometrium; Immunity

Indexed keywords

AROMATASE INHIBITOR; AUTOANTIBODY; CD4 ANTIGEN; CD5 ANTIGEN; CD8 ANTIGEN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DANAZOL; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 6; INTERLEUKIN 8; LEUKEMIA INHIBITORY FACTOR; LYMPHOTOXIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MIGRATION INHIBITION FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; RANTES; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULOTROPIN;

B LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL TRIAL; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; ENDOMETRIOSIS; ENDOMETRIUM CELL; FEMALE; GYNECOLOGIC DISEASE; HOMEOSTASIS; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOLOGY; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PATIENT CARE; PERITONEAL FLUID; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 2942751858     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2004.02.001     Document Type: Review

References (116)

1. Dmowski WP, Gebel HM & Braun DP. The role of cell-mediated immunity in pathogenesis of endometriosis. Acta Obstetericia et Gynecologica Scandinavica 1994; 159: 7-14.
2. Koninckx PR, Barlow D & Kennedy S. Implantation versus infiltration: the Sampson versus the endometriotic disease theory. Gynecologic and Obstetric Investigation 1999; 47: 3-10.
3. Rier SE & Yeaman GR. Immune aspects of endometriosis: relevance of the uterine mucosal immune system. Seminars in Reproductive Endocrinology 1997; 15(3): 209-220.
4. Vinatier D, Dufour P & Oosterlynck D. Immunological aspects of endometriosis. Human Reproduction 1996; 2(5): 371-384.
5. Vinatier D, Orazi G, Cossoa M & Dufour P. Theories of endometriosis. European Journal of Obstetric and Gynecologic Reproductive Biology 2001; 96(1): 21-34.
6. Lebovic DI, Mueller MD & Taylor RN. Immunobiology of endometriosis. Fertility and Sterility 2001; 75(1): 1-10.
7. Leyendecker G, Herbertz M, Kunz G & Mall G. Endometriosis results from the dislocation of basal endometrium. European Society of Human Reproduction 2002; 17(10): 2725-2736.
8. Gazvani R & Templeton A. New considerations for the pathogenesis of endometriosis. International Journal of Gynaecology and Obstetrics 2002; 76(2): 117-126.
9. Gebel HM, Braun DP, Tambur A et al. Spontaneous apoptosis of endometrial tissue is impaired in women with endometriosis. Fertility and Sterility 1998; 69(6): 1042-1047.
10. Braun DP & Dmowski WP. Endometriosis: abnormal endometrium and dysfunctional immune response. Obstetrics and Gynecology 1998; 10: 365-369.
11. Gurates B & Bulun SE. Endometriosis: the ultimate hormonal disease. Seminars in Reproductive Medicine 2003; 21(2): 125-134.
12. Kennedy S. Genetics of endometriosis: a review of the positional cloning approaches. Seminars in Reproductive Medicine 2003; 21(2): 111-118.
13. Giudice LC. Genomics' role in understanding the pathogenesis of endometriosis. Seminars in Reproductive Medicine 2003; 21(2): 119-124.
14. Ness RB. Endometriosis and ovarian cancer: thoughts on shared pathophysiology. American Journal of Obstetrics and Gynecology 2003; 189(1): 280-294.
15. Baranova H, Canis M, Ivaschenko T et al. Possible involvement of arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 genes in the development of endometriosis. Molecular Human Reproduction 1999; 5: 636-641.
16. Lin J, Zhang X & Chen Y. Mutagen sensitivity as a susceptibility marker for endometriosis. Human Reproduction 2003; 18(10): 2052-2057.
17. Rier S & Foster WG. Environment dioxins and endometriosis. Seminars in Reproductive Medicine 2003; 21(2): 145-153.
18. Dmowski WP, Steele RW & Baker GF. Deficient cellular immunity in endometriosis. American Journal of Obstetrics and Gynecology 1981; 141(4): 377-383.
19. Gleicher N, El-Roeiy A, Confino E & Friberg J. Abnormal autoantibodies in endometriosis: is endometriosis an autoimmune disease? Obstetrics and Gynecology 1987; 70: 115-122.
20. Hill JA. Immunology and endometriosis; fact, artifact, or epiphenomenon? Obstetrics and Gynecology. Clinics of North America 1997; 24(2): 291-306.
21. Zeller JM, Henig I, Radwanska E & Dmowski WP. Enhancement of human monocyte and peritoneal macrophage chemiluminescence activities in women with endometriosis. American Journal of Reproductive Immunology and Microbiology 1987; 13: 78.
22. Braun DP, Gebel H, House R et al. Spontaneous and induced synthesis of cytokines by peripheral blood monocytes in patients with endometriosis. Fertility and Sterility 1996; 65(6): 1125-1129.
23. Rana N, Braun DP, House R et al. Basal and stimulated secretion of cytokines by peritoneal macrophages in women with endometriosis. Fertility and Sterility 1996; 65(6): 925-930.
24. Karck U, Reister F, Schafer W et al. PGE2 and PGF2-alpha release by human peritoneal macrophages in endometriosis. Prostaglandins 1996; 51(1): 49-60.
25. Braun DP, Ding J & Dmowski WP. Peritoneal fluid-mediated enhancement of eutopic and ectopic endometrial cell proliferation is dependent on TNF-alpha is women with endometriosis. Fertility and Sterility 2002; 78: 727-732.
26. Santanam N, Song M, Rong R et al. Atherosclerosis, oxidation and endometriosis. Free Radical Research 2002; 36(12): 1315-1321.
27. Braun DP, Gebel H, Rotman C et al. The development of cytotoxicity in peritoneal macrophages from women with endometriosis. Fertility and Sterility 1992; 57(6): 1203-1210.
28. Oosterlynck DJ, Cornillie FJ, Waer M et al. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertility and Sterility 1991; 56: 45-51.
29. Lanier LL, Phillips JH & Inhibitory MHC. class I receptors on NK cells and T cells, a standard nomenclature. Immunology Today 1996; 17(2): 86-91.
30. Moretta L, Ciccone E, Moretta A et al. Allorecognition by NK cells: nonself or no self? Immunology Today 1992; 13: 300-306.
31. Maeda N, Izumiya C, Yamamoto Y et al. Increased killer inhibitory receptor KIR2DL1 expression among natural killer cells in women with pelvic endometriosis. Fertility and Sterility 2002; 77: 297-302.
32. Wu M, Yang J, Chao K et al. Increase in the expression of killer cell inhibitory receptors on peritoneal natural killer cells in women with endometriosis. Fertility and Sterility 2000; 74: 1187-1191.
33. Somigliana E, Vigano P, Gaffuri B et al. Modulation of NK cell lytic function by endometrial secretory factors: potential role in endometriosis. American Journal of Reproductive Immunology 1996; 36: 295-300.
34. Mazzeo D, Vigano P, Di Blasio A et al. Interleukin-12 and its free p40 subunit regulate immune recognition of endometrial cells: potential role in endometriosis. Journal of Clinical Endocrinology and Metabolism 1998; 83: 911-916.
35. Vigano P, Somigliana E, Di Blasio A et al. Suppression of natural killer cell function and production of soluble ICAM-I: endometrial stroma versus melanoma. American Journal of Reproductive Immunology 2001; 46: 342-348.
36. Fukaya T, Sugawara J, Yoshida H et al. Intercellular adhesion molecule-I and hepatocyte growth factor in human endometriosis: original investigation and a review of literature. Gynecologic and Obstetric Investigation 1999; 47: 11-17.
37. Startseva NV. Clinical immunological aspects of genital endometriosis. Akush Ginekol (Mosk) 1980; 3: 23-26.
38. Steele RW, Dmowski WP & Marmer DJ. Immunologic aspects of human endometriosis. American Journal of Reproductive Immunology 1984; 6: 33-36.
39. Weed JC & Arguembourg PC. Endometriosis: can it produce an autoimmune response resulting in infertility? Clinical Obstetrics and Gynecology 1980; 23: 885-893.
40. Mathur S, Peress MR, Williamson HO et al. Autoimmunity to endometrium and ovary in endometriosis. Clinical Experiments in Immunology 1982; 50: 259-266.
41. Mathur SP. Autoimmunity in endometriosis: relevance to infertility. American Journal of Reproductive Immunology 2000; 44: 89-95.
42. Nothnick WB. Treating endometriosis as an autoimmune disease. Fertility and Sterility 2001; 76(2): 223-231.
43. Seli E & Arici A. Endometriosis: interaction of immune and endocrine systems. Seminars in Reproductive Medicine 2003; 21(2): 135-144.
44. Dmowski WP & Braun DP. Immunologic Aspects of Endometriosis. Diamond and Osteen, Endometrium and Endometriosis. Blackwell Science, 1997. pp. 174-181.
45. Yeaman GR, Collins JE & Lang GA. Autoantibody responses to carbohydrate epitopes in endometriosis. Annals of New York Academy of Science 2002; 955: 174-182.
46. Dmowski WP, Rana N, Michalowska J et al. The effect of endometriosis, its stage and activity, and of autoantibodies on in vitro fertilization and embryo transfer success rates. Fertility and Sterility 1995; 63: 555-562.
47. Gleicher N, Vidali A & Karande V. The immunological 'wars of the roses 17(3): 539-542.
48. Ramey JW & Archer DF. Peritoneal fluid: its relevance to the development of endometriosis. Fertility and Sterility 1993; 60(1): 1-14.
49. Oral E, Olive DL & Arici A. The peritoneal environment in endometriosis. Human Reproduction 1996; 2(5): 385-398.
50. Oral E & Arici A. Peritoneal growth factors and endometriosis. Seminars in Reproductive Endocrinology 1996; 14(3): 257-267.
51. Kayisli UA, Mahutte NG & Arici A. Uterine chemokines in reproductive physiology and pathology. American Journal of Reproductive Immunology 2002; 47: 213-221.
52. Garcia-Velasco JA & Arici A. Chemokines and human reproduction. Fertility and Sterility 1999; 71(6): 983-993.
53. Harada T, Iwabe T & Terakawa N. Role of cytokines in endometriosis. Fertility and Sterility 2001; 76(supplement 1): 1-10.
54. Koninckx PR, Kennedy SH & Barlow DH. Pathogenesis of endometriosis: the role of peritoneal fluid. Gynecologic and Obstetric Investigation 1999; 47(1): 23-33.
55. Van Langendonckt A, Casanas-Roux F & Donnez J. Oxidative stress and peritoneal endometriosis. Fertility and Sterility 2002; 77(5): 861-870.
56. Song M, Karabina S, Kavtaradze N et al. Presence of endometrial epithelial cells in the peritoneal cavity and the mesothelial inflammatory response. Fertility and Sterility 2003; 79(supplement 1): 789-794.
57. Kitaya K, Nakayama T, Okubo T et al. Expression of macrophage inflammatory protein-Ibeta in human endometrium: its role in endometrial recruitment of natural killer cells. Journal of Clinical Endocrinology and Metabolism 2003; 88: 1809-1814.
58. Szamatowicz J, Laudanski P, Tomaszewska I & Szamatowicz M. Chemokine growth-regulated-alpha: a possible role in pathogenesis of endometriosis. Gynecologic Endocrinology 2002; 16: 137-141.
59. Pizzo A, Salmeri F, Ardita F et al. Behavior of cytokine levels in serum and peritoneal fluid of women with endometriosis. Gynecologic and Obstetric Investigation 2002; 54: 82-87.
60. Jolicoeur C, Boutouil M, Drouin R et al. Increased expression of monocyte chemotactic protein-I in the endometrium of women with endometriosis. American Journal of Pathology 1998; 152: 125-133.
61. Khorram O, Taylor RN, Ryan IP et al. Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis. Americon Journal of Obstetrics and Gynecology 1993; 169: 1545-1549.
62. Hornung D, Klingel K, Dohrn K et al. Regulated on activation, normal t-cell-expressed and -secreted mRNA expression in normal endometrium and endometriotic implants: assessment of autocrine/paracrine regulation by in situ hybridization. American Journal of Pathology 2001; 158: 1949-1954.
63. Akoum A, Lemay A & Maheux R. Estradiol and interleukin-1 beta exert a synergistic stimulatory effect on the expression of the chemokine regulated upon activation, normal T cell expressed, and secreted in endometriotic cells. Journal of Clinical Endocrinology Metabolism 2002; 87: 5785-5792.
64. Nasu K, Fukuda J, Sun B et al. Interleukin-13 and tumor necrosis factor-beta differentially regulate the production of cytokines by cultured human endometrial stromal cells. Fertility and Sterility 2003; 79: 821-827.
65. Sillem M, Prifti S, Monga B et al. Integrin-mediated adhesion of uterine endometrial cells from endometriosis patients to extracellular matrix proteins is enhanced by tumor necrosis factor alpha (TNF alpha) and interleukin-1 (IL-1). Europeon Journal of Obstetrics and Gynaecology of Reproduction Biology 1999; 87: 123-127.
66. Sillem M, Prifti S, Koch A et al. Regulation of matrix metalloproteinases and their inhibitors in uterine endometrial cells of patients with and without endometriosis. European Journal of Obstetrics and Gynecological Reproduction Biology 2001; 95: 167-174.
67. Bruner-Tran K, Eisenberg E, Yeaman G et al. Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice. Journal of Clinical Endocrinology and Metabolism 2002; 87: 4782-4791.
68. McLaren J, Prentice A, Charnock-Jones DS et al. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. Journal of Clinical Investigation 1996; 98: 482-489.
69. Ria R, Loverro G, Ribatti D et al. Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 agree with progression of ovarian endometriomas. European Journal of Clinical Investigation 2002; 32: 199-206.
70. Lebovic DI, Bentzien F, Chao VA et al. Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1beta. Molecular Human Reproduction 2000; 6: 269-275.
71. Akoum A, Lawson C, McColl S & Villeneuve M. Ectopic endometrial cells express high concentrations of interleukin (IL)-8 in vivo regardless of the menstrual cycle phase and respond to oestradiol by upregulating IL-1-induced IL-8 expression in vitro. Molecular Human Reproduction 2001; 7: 859-866.
72. Bartz E, Rozewska ES, Kaminski P et al. Angiogenic activity and IL-8 concentrations in peritoneal fluid and sera in endometriosis. International Journal of Gynaecology and Obstetrics 2002; 79: 229-235.
73. Maas JW, Calhaz-Jorge C, ter Riet G et al. Tumor necrosis factor-alpha but not interleukin-1 beta or interleukin-8 concentrations correlate with angiogenic activity of peritoneal fluid from patients with minimal to mild endometriosis. Fertility and Sterility 2001; 75: 180-185.
74. Arici A, Matalliotakis I, Goumenou A et al. Increased levels of interleukin-15 in the peritoneal fluid of women with endometriosis: inverse correlation with stage and depth of invasion. Human Reproduction 2003; 18: 429-432.
75. Kats R, Collette T, Metz C & Akoum A. Marked elevation of macrophage migration inhibitory factor in the peritoneal fluid of women with endometriosis. Fertility and Sterility 2002; 78: 69-76.
76. Iwabe T, Harada T, Sakamoto Y et al. Gonadotropin-releasing hormone agonist treatment reduced serum interleukin-6 concentrations in patients with ovarian endometriomas. Fertility and Sterility 2003; 80(2): 300-304.
77. Arici A, Tazuke SI, Attar E et al. Interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukin-8 expression in human mesothelial cells. Molecular Human Reproduction 1996; 2: 40-45.
78. Iwabe T, Harada T, Tsudo T et al. Tumor necrosis factor-alpha promotes proliferation of endometriotic stromal cells by inducing interleukin-8 gene and protein expression. Journal of Clinical Endocrinology and Metabolism 2000; 85: 824-829.
79. Witz CA, Montoya IA, Dey TD & Schenken RS. Characterization of lymphocyte subpopulations and T cell activation in endometriosis. American Journal of Reproductive Immunology 1994; 32: 173-179.
80. Oosterlynck DJ, Cornillie FJ, Waer M & Koninckx PR. Immunohistochemical characterization of leucocyte subpopulations in endometriotic lesions. Archives of Gynecology and Obstetrics 1993; 253: 197-206.
81. Bulmer JN, Jones RK & Searle RF. Intraepithelial leukocytes in endometriosis and adenomyosis: comparison of eutopic and ectopic endometrium with normal endometrium. Human Reproduction 1998; 13: 2910-2915.
82. Jones RK, Bulmer JN & Searle RF. Phenotypic and functional studies of leukocytes in human endometrium and endometriosis. Human Reproduction Update 1998; 4: 702-709.
83. Ho HN, Wu MY, Chao KH et al. Peritoneal interleukin-10 increases with decrease in activated CD4 + T lymphocytes in women with endometriosis. Human Reproduction 1997; 12: 2528-2533.
84. Mettler L, Volkov NI, Kulakov VI et al. Lymphocyte subsets in the endometrium of patients with endometriosis throughout the menstrual cycle. American Journal of Reproductive Immunology 1996; 36: 342-348.
85. Braun DP, Ding J, Shen J et al. Relationship of apoptosis and macrophage numbers in eutopic endometrium of women with and without endometriosis. Fertility and Sterility 2002; 78: 830-835.
86. Chiang CM & Hill JA. Localization of T cells, interferon-gamma and HLA-DR in eutopic and ectopic human endometrium. Gynecologic and Obstetric Investigation 1997; 43: 245-250.
87. Ho H, Wu M, Chao K et al. Decrease in interferon gamma production and impairment of T-lymphocyte proliferation in peritoneal fluid of women with endometriosis. American Journal of Obstetrics and Gynecology 1996; 175: 1236-1241.
88. Braun DP, Gebel H, Rana N et al. Peritoneal macrophage function in women with endometriosis. Fertility and Sterility 1992; 57: 1203-1210.
89. Maeda N, Izumiya C, Oguri H et al. Aberrant expression of intercellular adhesion molecule-I and killer inhibitory receptors induces immune tolerance in women with pelvic endometriosis. Fertility and Sterility 2002; 77: 679-683.
90. Izumiya C, Maeda N, Kusume T et al. Coordinated but depressed expression of human leukocyte antigen-DR, intercellular adhesion molecule-I, and CD14 on peritoneal macrophages in women with pelvic endometriosis. Fertility and Sterility 2003; 80: 768-775.
91. Semino C, Semino A, Pietra G et al. Role of major histocompatibility complex class I expression and natural killer-like T cells in the genetic control of endometriosis. Fertility and Sterility 1995; 64: 909-916.
92. Garcia-Velasco J, Arici A, Zreik T et al. Macrophage derived growth factors modulate Fas ligand expression in cultured endometrial stromal cells: a role in endometriosis. Molecular Human Reproduction 1999; 5: 642-650.
93. Selam B, Kayisli U, Garcia-Velasco J et al. Regulation of fas ligand expression by IL-8 in human endometrium. Journal of Clinical Endocrinology and Metabolism 2002; 87: 3921-3927.
94. Selam B, Kayisli U, Garcia-Velasco J & Arici A. Extracellular matrix-dependent regulation of Fas ligand expression in human endometrial stromal cells. Biology of Reproduction 2002; 66: 1-5.
95. Garcia-Velasco J, Mulayim N, Kayisli U & Arici A. Elevated soluble Fas ligand levels may suggest a role for apoptosis in women with endometriosis. Fertility and Sterility 2002; 78: 855-859.
96. Sinaii N, Cleary SD, Ballweg ML et al. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Human Reproduction 2002; 17(10): 2715-2724.
97. Brinton LA, Gridley G, Persson I et al. Cancer risk after a hospital discharge diagnosis of endometriosis. American Journal of Obstetrics and Gynecology 1997; 176(3): 572-579.
98. Wood DH, Yochmowitz MG, Salmon YL et al. Proton irradiation and endometriosis. Aviation, Space, and Environmental Medicine 1983; 54: 718-724.
99. Campbell JS, Wong J, Tryphonas H, et al. Is simian endometriosis an effect of immunotoxicity? Presented at the Annual Meeting, Ontario Association of Pathologists, London, Ontario, 1985.
100. Rier SE, Martin DC, Bowman RE et al. Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetrachlorodilbenzo-p-dioxin. Fundamental Application of Toxicology 1993; 21: 433-441.
101. Runnebaum G & Runnebaum B. Fertility disorders may result from heavy metal and pesticide contamination which limits effectiveness of hormone therapy. Zentralbl Gynakol 1992; 114: 593-602.
102. Yang JZ, Agarwal SK & Foster WG. Subchorionic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin modulates the pathophysiology of endometriosis in the cynomolgus monkey. Toxicological Sciences 2000; 56: 374-381.
103. Cummings AM, Mercalf JL & Birnbaum L. Promotion of endometriosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats and mice: time-dose dependence and species comparison. Toxicology and Applied Pharmacology 1996; 138: 131-139.
104. Bruner-Tran K, Rier SE, Eisenberg E, Osteen KG. The potential role of environmental toxins in the pathophysiology of endometriosis. Gynecologic and Obstetric Investigation, 1999;48:45-56.
105. Meresman G, Vighi S, Buquet R et al. Apoptosis and expression of bcl-2 and bax in eutopic endometrium from women with endometriosis. Fertility and Sterility 2000; 74: 760-766.
106. Jones RK, Searle RF & Bulmer JN. Apoptosis and bcl-2 expression in normal human endometrium, endometriosis and adenomyosis. Human Reproduction 1998; 13: 3496-3502.
107. Ueda M, Yamashita Y, Takehara M et al. Surviving gene expression in endometriosis. Journal of Clinical Endocrinology and Metabolism 2002; 87: 3452-3459.
108. Meresman G, Bilotas M, Buquet R et al. Gonadotropin-releasing hormone agonist induces apoptosis and reduces cell proliferation in eutopic endometrial cultures from women with endometriosis. Fertility and Sterility 2003; 80: 702-707.
109. Mizutani T, Sugihara A, Nakamuro K et al. The gonadotropin-releasing hormone agonist leuprolide acetate induces apoptosis and suppresses cell proliferative activity in rectovaginal endometriosis. American Journal of Obstetrics and Gynecology 1999; 181: 750-751.
110. Braun DP, Gebel H & Dmowski WP. Effect of danazol in vitro and in vivo on monocyte-mediated enhancement of endometrial cell proliferation in women with endometriosis. Fertility and Sterility 1994; 62: 89-95.
111. D'Antonio M, Martelli F & Peano S. Ability of recombinant human TNF binding protein-I (r-hTBP-I) to inhibit the development of experimentally-induced endometriosis in rats. Journal of Reproductive Immunology 2000; 48: 81-98.
112. Ota H, Igarashi S, Sasaki M & Tanaka T. Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis. Human Reproduction 2001; 16: 561-566.
113. Chishima F, Hayakawa S, Sugita K et al. Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients. American Journal of Reproductive Immunology 2002; 48: 50-56.
114. Wu M, Sun HS, Lin C et al. Distinct mechanisms regulate cyclooxygenase-1 and -2 in peritoneal macrophages of women with and without endometriosis. Molecular Human Reproduction 2002; 8: 1103-1110.
115. Noble LS, Takayama K, Zeitown KM et al. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. Journal of Clinical Endocrinology and Metabolism 1997; 82(2): 600-606.
116. Braun DP. In Harris JE & Braun DP (eds) The Impact of Prostaglandins on Cancer Patient Immunity: In Prostaglandin Inhibitors in Tumor Immunology and Immunotherapy. Boca Raton, FL: CRC Press, 1994, pp 109-129.